Modern Diagnost.

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE1HK501016
  • NSEID:
  • BSEID: 544673
INR
59.50
0.00 (0.00%)
BSENSE

Jun 03, 03:30 PM

BSE+NSE Vol: 4800

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

4.8 k (-76.56%) Volume

Shareholding (Mar 2026)

FII

0.03%

Held by 1 FIIs

DII

15.49%

Held by 1 DIIs

Promoter

72.85%

When is the next results date for Modern Diagnostic & Research Centre Ltd?

22-May-2026

The next results date for Modern Diagnostic & Research Centre Ltd is 29 May 2026.

The next results date for Modern Diagnostic & Research Centre Ltd is scheduled for 29 May 2026.

View full answer

Which are the latest news on Modern Diagnost.?

03-Jun-2026

Why is Modern Diagnostic & Research Centre Ltd falling/rising?

04-Jun-2026

As of 03-Jun, Modern Diagnostic & Research Centre Ltd's stock is at Rs 59.50, up 4.39% today, but it remains below all key moving averages, indicating a longer-term downtrend and declining investor participation.

As of 03-Jun, Modern Diagnostic & Research Centre Ltd's stock price is rising, currently at Rs 59.50, reflecting a change of Rs 2.5 or 4.39%. The stock has shown a positive performance today, outperforming its sector by 2.82%. It has been gaining for the last two days, with a total increase of 7.99% during this period. Additionally, the stock opened with a gain of 3.51% today and reached an intraday high of Rs 60, which is a 5.26% increase.<BR><BR>Despite these positive movements, it is important to note that the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a longer-term downtrend. Furthermore, there has been a decline in investor participation, with delivery volume falling by 2.78% compared to the 5-day average. This suggests that while the stock is currently experiencing a rise, there are underlying factors such as lower trading volumes and moving averages that could impact its future performance.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Healthcare Services

stock-summary
Market cap

INR 86 Cr (Micro Cap)

stock-summary
P/E

17.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

1.03

stock-summary
Return on Equity

25.33%

stock-summary
Price to Book

4.15

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-21.09%
0%
-21.09%
6 Months
0%
0%
0.0%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Modern Diagnost. for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

Announcements stock-summary

Financial Results For The Half Year And Year Ended 31.03.2026

29-May-2026 | Source : BSE

Financial results for the half year and year ended 31 March 2026

Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 & 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

29-May-2026 | Source : BSE

Pursuant to Regulation 30 & 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you hereby informed that the Board of Directors in its meeting held on May 29 2026 have inter-alia considered and approved the following matters: a. approved the Audited Financial Results of the Company for the half year/year ended March 31 2026 along with Statement of Assets & Liabilities and Cash Flow Statement of the Company for the period ended March 31 2026. b. Taken on record the Independent Auditors Report submitted by the Statutory Auditors on Financial Result for the half year / year ended March 31 2026

Compliances-Reg.24(A)-Annual Secretarial Compliance

28-May-2026 | Source : BSE

Disclosure regarding non-applicability of Regulation 24A of SEBI (LODR) Regulations 2015

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
4.73
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
12.35%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
15.51%
ROCE (avg)
0
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
17
Industry P/E
0
Price to Book Value
4.33
EV to EBIT
15.02
EV to EBITDA
8.83
EV to Capital Employed
2.64
EV to Sales
1.34
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
17.60%
ROE (Latest)
25.33%

Technicals key factors

Indicator
Weekly
Monthly
MACD
RSI
No Signal
Bollinger Bands
Sideways
KST
Dow Theory
Mildly Bearish
OBV
Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 1 FIIs (0.03%)

Promoter with highest holding

Devendra Singh Yadav (61.2%)

Highest Public shareholder

Aarth Aif Growth Fund (4.48%)

Individual Investors Holdings

4.75%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Modern Diagnost."
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "39.98",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "9.67",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.95",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "4.96",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "24.19%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Modern Diagnost."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "77.95",
          "val2": "67.13",
          "chgp": "16.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "17.97",
          "val2": "11.05",
          "chgp": "62.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.91",
          "val2": "1.81",
          "chgp": "5.52%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "8.97",
          "val2": "5.79",
          "chgp": "54.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "23.05%",
          "val2": "16.46%",
          "chgp": "6.59%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary

Sep'24
Change(%)
Net Sales
39.98
NA
NA
Operating Profit (PBDIT) excl Other Income
9.67
NA
NA
Interest
0.95
NA
NA
Exceptional Items
0.00
NA
NA
Standalone Net Profit
4.96
NA
NA
Operating Profit Margin (Excl OI)
24.19%
NA%
NA
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

Annual Results Snapshot (Standalone) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
77.95
67.13
16.12%
Operating Profit (PBDIT) excl Other Income
17.97
11.05
62.62%
Interest
1.91
1.81
5.52%
Exceptional Items
0.00
0.00
Standalone Net Profit
8.97
5.79
54.92%
Operating Profit Margin (Excl OI)
23.05%
16.46%
6.59%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

stock-summaryCompany CV
About Modern Diagnostic & Research Centre Ltd stock-summary
stock-summary
Modern Diagnostic & Research Centre Ltd
Micro Cap
Healthcare Services
The Promoter, Mr. Devendra Singh Yadav started its operations of Diagnostic Centre in the name and style of 'Modern X-Ray and Clinical Lab' as Proprietorship firm in year 1985, which was later designated as 'Modern Diagnostic & Research Centre' in 1992. Modern Diagnostic & Research Centre Limited was erstwhile incorporated as "Modern Diagnostic & Research Centre Private Limited" as a private company, vide Certificate of Incorporation dated April 16, 2012 issued by Registrar of Companies, Delhi .
Company Coordinates stock-summary
Icon
No Company Details Available